×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| IOL CHEMICALS & PHARMACEUTICAL | 5590.6 | 339.6 | 5516.9 | 1.16 | 3,256 | 31.0 |
| HIKAL LTD. | 3814.0 | -227.0 | 3804.0 | -1.84 | 3200 | 50.6 |
| SOLARA ACTIVE PHARMA SCIENCES | 3201.3 | 105.2 | 3191.5 | 2.46 | 3007 | 123.0 |
IOL Chemicals & Pharmaceuticals Ltd, with Security Code 524164, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 587.2 | 563.2 | 545.3 | 520.4 | 503.9 | 502.4 | 525.8 | 523.3 | 527.8 | 551.7 |
| Expenses | 491.4 | 490.3 | 481.2 | 475.9 | 453.8 | 451.6 | 484.2 | 476.4 | 464.8 | 489.5 |
| Operating Profit | 95.8 | 72.9 | 64.1 | 44.5 | 50.1 | 50.8 | 41.6 | 46.9 | 62.9 | 62.2 |
| OPM % | 16.31% | 12.94% | 11.75% | 8.55% | 9.94% | 10.11% | 7.9% | 8.96% | 11.93% | 11.27% |
| Other Income | 8.7 | 7.1 | 7.1 | 8.4 | 7.5 | 7.4 | 6.4 | 4.1 | 4.5 | 7.4 |
| Interest | 4.9 | 4.0 | 4.4 | 4.3 | 3.4 | 2.2 | 4.1 | 4.5 | 4.0 | 4.2 |
| Depreciation | 12.1 | 14.4 | 15.7 | 16.3 | 16.4 | 16.8 | 17.9 | 18.7 | 18.5 | 19.8 |
| Profit before tax | 87.5 | 61.5 | 51.1 | 32.2 | 37.8 | 39.2 | 25.9 | 27.8 | 44.9 | 45.5 |
| Tax % | -25.4% | -24.9% | -26% | -27.9% | -25.4% | -24.3% | -26.2% | 26.1% | -29.4% | 25.4% |
| Net Profit | 65.3 | 46.2 | 37.8 | 23.2 | 28.2 | 29.7 | 19.2 | 20.6 | 31.6 | 34.0 |
| EPS in Rs | 2.22 | 1.57 | 1.29 | 0.79 | 0.96 | 1.01 | 0.65 | 0.7 | 0 | 1.16 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 523.5 | 587.2 | 563.2 | 545.3 | 520.4 | 503.9 | 502.4 | 525.8 | 523.3 | 527.8 |
| Expenses | 480.8 | 491.9 | 490.7 | 481.1 | 476.0 | 454.4 | 451.3 | 484.2 | 476.4 | 465.0 |
| Operating Profit | 42.7 | 95.3 | 72.5 | 64.2 | 44.4 | 49.5 | 51.1 | 41.6 | 46.9 | 62.8 |
| OPM % | 8.16% | 16.23% | 12.88% | 11.77% | 8.52% | 9.83% | 10.17% | 7.91% | 8.96% | 11.89% |
| Other Income | 6.7 | 8.7 | 7.1 | 7.1 | 8.4 | 7.5 | 7.4 | 6.4 | 4.1 | 4.5 |
| Interest | 4.7 | 4.9 | 4.0 | 4.4 | 4.3 | 3.4 | 2.2 | 4.1 | 4.5 | 4.0 |
| Depreciation | 11.8 | 12.1 | 14.5 | 15.7 | 16.3 | 16.4 | 16.8 | 17.9 | 18.7 | 18.6 |
| Profit before tax | 32.9 | 87.0 | 61.2 | 51.2 | 32.1 | 37.2 | 39.5 | 25.9 | 27.8 | 44.7 |
| Tax % | -27.7% | -25.6% | -25% | -26% | -28.1% | -25.8% | 24.2% | 26.2% | -26.2% | -29.5% |
| Net Profit | 23.8 | 64.8 | 45.9 | 37.9 | 23.1 | 27.6 | 30.0 | 19.2 | 20.5 | 31.4 |
| EPS in Rs | 0.81 | 2.21 | 1.56 | 1.29 | 0.79 | 0.94 | 1.02 | 0.65 | 3.5 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 2% |
| 3 Years: | -2% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | -23% |
| 3 Years: | -17% |
| TTM: | -25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 1% |
| 3 Years: | 4% |
| 1 Year: | 16% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -2% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | -17% |
| TTM: | -25% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 1% |
| 3 Years: | 4% |
| 1 Year: | 16% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|